Sunday, September 6, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· January 23, 2026

AI in Medical Imaging Market Size to Hit Nearly USD 22.97 Trillion by 2035, Driven by Rising Demand for Early Disease Detection and Workflow Automation

View original at globenewswire.com
AI in Medical Imaging Market Size to Hit Nearly USD 22.97 Trillion by 2035, Driven by Rising Demand for Early Disease Detection and Workflow Automation Ottawa, Jan…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Over $3 billion in private funding has gone to AI imaging startups in the past 5 years

    80% confidence
  • North America holds 45% share of AI medical imaging market in 2025, the largest regional share

    80% confidence
  • There is a 30-40% global radiologist workforce shortage

    80% confidence
  • Asia-Pacific is the fastest growing region at 30.80% CAGR

    80% confidence
  • AI is present in approximately 35% of large hospitals as of 2025

    80% confidence
  • U.S. AI medical imaging market will grow from $716.22B in 2025 to $7,640.97B in 2034 at 26.71% CAGR

    80% confidence
  • Deep learning holds 48% market share with $970.58B revenue in 2025, the dominant technology

    80% confidence
  • Global AI in medical imaging market will grow from $2.01 trillion in 2025 to $22.97 trillion in 2035 at 27.57% CAGR

    80% confidence
  • China accounts for over 35% of Asia-Pacific AI medical imaging growth

    80% confidence
  • 70% of global deaths are from chronic diseases including cancer, cardiovascular, neurological, and respiratory conditions

    80% confidence
  • Explainable AI is the fastest growing technology segment at approximately 30% CAGR

    80% confidence
  • AI delivers 30-50% reduction in reporting turnaround time and 20-30% improvement in diagnostic accuracy

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com